Corrigendum to "Effects of dialysate potassium concentration of 3.0 mmol/l with sodium zirconium cyclosilicate on dialysis-free days versus dialysate potassium concentration of 2.0 mmol/l alone on rates of cardiac arrhythmias in hemodialysis patients with hyperkalemia." Kidney International 2025;107:169-179

Affiliations

¹ Division of Nephrology, Department of Medicine, New York University Grossman School of Medicine, New York, New York, USA.
² Section of Nephrology, Department of Medicine, Baylor College of Medicine, Houston, Texas, USA.
³ Duke Clinical Research Institute, Duke University, Durham, North Carolina, USA; Division of Cardiovascular Medicine, Duke University, Durham, North Carolina, USA.
⁴ Division of Nephrology, Department of Medicine, Duke University Medical Center, Durham, North Carolina, USA.
⁵ Cardiology Division, Department of Internal Medicine, Hennepin Healthcare/University of Minnesota, Minneapolis, Minnesota, USA.
⁶ Division of Nephrology, Department of Medicine, Stanford University School of Medicine, Stanford, California, USA.
⁷ BioPharmaceuticals, Medical Evidence Statistics, AstraZeneca Pharmaceuticals LP, Wilmington, Delaware, USA.
⁸ NephroNet, Atlanta, Georgia, USA.
⁹ NephroNet, Atlanta, Georgia, USA; Division of Renal Medicine, Emory University School of Medicine, Atlanta, Georgia, USA. Electronic address: jtumlin@nephronet.com.

Free article

Published Erratum

David M Charytan et al. Kidney Int. 2025 Jun.

Free article

. 2025 Jun;107(6):1123.

doi: 10.1016/j.kint.2025.03.009.

¹ Division of Nephrology, Department of Medicine, New York University Grossman School of Medicine, New York, New York, USA.
² Section of Nephrology, Department of Medicine, Baylor College of Medicine, Houston, Texas, USA.
³ Duke Clinical Research Institute, Duke University, Durham, North Carolina, USA; Division of Cardiovascular Medicine, Duke University, Durham, North Carolina, USA.
⁴ Division of Nephrology, Department of Medicine, Duke University Medical Center, Durham, North Carolina, USA.
⁵ Cardiology Division, Department of Internal Medicine, Hennepin Healthcare/University of Minnesota, Minneapolis, Minnesota, USA.
⁶ Division of Nephrology, Department of Medicine, Stanford University School of Medicine, Stanford, California, USA.
⁷ BioPharmaceuticals, Medical Evidence Statistics, AstraZeneca Pharmaceuticals LP, Wilmington, Delaware, USA.
⁸ NephroNet, Atlanta, Georgia, USA.
⁹ NephroNet, Atlanta, Georgia, USA; Division of Renal Medicine, Emory University School of Medicine, Atlanta, Georgia, USA. Electronic address: jtumlin@nephronet.com.

No abstract available

Erratum for

Effects of dialysate potassium concentration of 3.0 mmol/l with sodium zirconium cyclosilicate on dialysis-free days versus dialysate potassium concentration of 2.0 mmol/l alone on rates of cardiac arrhythmias in hemodialysis patients with hyperkalemia.
Charytan DM, Winkelmayer WC, Granger CB, Middleton JP, Herzog CA, Chertow GM, Eudicone JM, Whitson JD, Tumlin JA; ADAPT Investigators. Charytan DM, et al. Kidney Int. 2025 Jan;107(1):169-179. doi: 10.1016/j.kint.2024.10.010. Epub 2024 Oct 26. Kidney Int. 2025. PMID: 39490411 Clinical Trial.